CGTN AMERICA & CCTV UN: Global Dialogue on Innovation, Openness and Shared Development
WASHINGTON, Oct. 23, 2025 /PRNewswire/ -- CGTN America & CCTV UN releases "Global Dialogue on Innovation, Openness and Shared Development" China Media Group will host a media event on Friday, October 24, at the Embassy of the People's Republic...
AMBITIONS ENTERPRISE MANAGEMENT CO. L.L.C Announces Pricing of Initial Public Offering
DUBAI, UAE, Oct. 21, 2025 /PRNewswire/ -- AMBITIONS ENTERPRISE MANAGEMENT CO. L.L.C, (the "Company") (NASDAQ: AHMA), a UAE-based MICE (meetings, incentives, conferences, and exhibitions) and tourism services provider, today announced the pricing of...
The Ritz-Carlton, Bali Named as "Indonesia's Best Hotel Spas" in Travel+Leisure Luxury Awards Asia Pacific 2025
Download image: https://marrstar.box.com/s/0yabr8z44cj6mgma4xwoawyrryikwqhq BALI, Indonesia, June 24, 2025 /PRNewswire/ -- The Ritz-Carlton, Bali, a premier beachfront sanctuary nestled on shores of Bali, is proud to announce its prestigious win as...
Bright Scholar Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee
CAMBRIDGE, England and FOSHAN, China, June 20, 2025 /PRNewswire/ -- Bright Scholar Education Holdings Limited ("Bright Scholar" or the "Company") (NYSE: BEDU), a global premier education service company, today announced that the independent special...
Paradigm Therapeutics, Inc. Announces an Additional Investment by Eshelman Ventures, LLC to Expedite Global Development and Global Registration of SD-101, A Topical Therapy for Treatment Across the Entire Skin Surface of All Subtypes of Epidermolysis Bull
First Topical Therapy Developed to Treat the Wounds and Lesions on the Entire Skin Surface Across All EB Subtypes Funding to be Used to Accelerate Activities Associated with Increasing Manufacturing Development of SD-101 and Commercial Launch of the...
Paradigm Therapeutics, Inc. Announces Investment by Eshelman Ventures, LLC to Support Completion of Development of SD-101 (Zorblisa™), A Topical Therapy for Treatment Across the Entire Skin Surface of All Subtypes of Epidermolysis Bullosa (EB)
First Topical Therapy Developed to Treat the Wounds and Lesions on the Entire Skin Surface Across All EB Subtypes Funding to be Used for Completion of All Activities to Support Planned NDA Submission in the Second Half of 2025, Along with Plans for...
ROHM Develops New High-power-density SiC Power Modules
- Compact, High-heat-dissipation Design Sets New Standard for OBC - KYOTO, Japan, April 24, 2025 /PRNewswire/ -- ROHM Co., Ltd. has developed new 4-in-1 and 6-in-1 SiC molded modules in the HSDIP20 package for power-factor-correction (PFC) circuits...
Heng Ren Partners Calls on Sinovac to Disclose the Record and Payment Dates of the Special Dividend and Distribute an Additional Dividend of $41 per Share
BOSTON, April 11, 2025 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) shareholder Heng Ren Partners, LLC sent a letter on April 8, 2025, to Sinovac's Board calling on the Board to disclose the record and payment dates of the special cash...
Enfinity Global Statement on CEO Carlos Domenech
MIAMI, April 2, 2025 /PRNewswire/ -- As stated in the press release issued by TerraForm Power Parent, LLC on April 1, 2025, via GlobeNewswire: "On January 20, 2025, a lawsuit filed in the United States District Court for the District of Maryland...
Heng Ren Partners Demands Sinovac Distribute $8.9 Billion in Cash to its Shareholders and Cause Reinstatement of Trading
BOSTON, March 20, 2025 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) ("Sinovac") shareholder Heng Ren Partners, LLC funds ("Heng Ren") today sent an open letter to Sinovac's shareholders outlining the significant and decisive action that...